Escape of HIV-1 from a CCR5 antagonist can reduce envelope-mediated entry

被引：0
|
作者：
Huang, W. [1 ]
Wojcik, L. [2 ]
Toma, J. [1 ]
Fransen, S. [1 ]
Stawiski, E. [1 ]
Whitcomb, J. [1 ]
Parkin, N. [1 ]
Strizki, J. [2 ]
Petropoulos, C. [1 ]
机构：
[1] Monogram Biosci, San Francisco, CA USA
[2] Schering Plough Res Inst, Kenilworth, NJ 07033 USA
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A65 / A65
页数：1
相关论文
共 50 条
  • [1] Tracking Dynamic HIV-1 Escape from CCR5 Antagonist Therapy in vivo by Deep Sequencing
    Tsibris, Athe M. N.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 26 - 26
  • [2] CCR5 antagonist-resistant HIV-1 entry kinetics as a function of CD4 and CCR5 surface expression
    Putcharoen, O.
    Lee, S-H
    Henrich, T. J.
    Vanichanan, J.
    Kuritzkes, D. R.
    Tsibris, A. M. N.
    ANTIVIRAL THERAPY, 2011, 16 : A64 - A64
  • [3] Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies
    Kuwata, Takeo
    Enomoto, Ikumi
    Baba, Masanori
    Matsushita, Shuzo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 437 - 450
  • [4] HIV-1 escape from small molecule CCR5 inhibitors in vitro
    Kuhmann, Shawn
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [5] HIV-1 Escape From Small Molecule CCR5 Inhibitors In Vitro
    Shawn Kuhmann
    Retrovirology, 2
  • [6] Maraviroc - a CCR5 antagonist for the treatment of HIV-1 infection
    Van Der Ryst, Elna
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [7] Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope
    Staudinger, R
    Wang, XH
    Bandrés, JC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 286 (01) : 41 - 47
  • [8] The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1
    Olivieri, Kevin
    Scoggins, Robert M.
    Bor, Yeou-cherng
    Matthews, Aprille
    Mark, David
    Taylor, James R., Jr.
    Chernauskas, David
    Hammarskjold, Marie-Louise
    Rekosh, David
    Camerini, David
    VIROLOGY, 2007, 358 (01) : 23 - 38
  • [9] Interaction of small molecule inhibitors of HIV-1 entry with CCR5
    Seibert, Christoph
    Ying, Weiwen
    Gavrilov, Svetlana
    Tsamis, Fotini
    Kuhmann, Shawn E.
    Palani, Anandan
    Tagat, Jayaram R.
    Clader, John W.
    McCombie, Stuart W.
    Baroudy, Bahige M.
    Smith, Steven O.
    Dragic, Tatjana
    Moore, John P.
    Sakmar, Thomas P.
    VIROLOGY, 2006, 349 (01) : 41 - 54
  • [10] Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc
    Latinovic, Olga
    Kuruppu, Janaki
    Davis, Charles
    Le, Nhut
    Heredia, Alonso
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1497 - 1510
12345